Syra Health Corp 8-K

What Happened

• Syra Health Corp (SYRA) announced its financial results for the first quarter ended March 31, 2026 via a press release dated May 7, 2026. The press release is furnished as Exhibit 99.1 to the Form 8-K. The filing notes the exhibit includes forward‑looking statements and that the furnished information is not deemed “filed” under Section 18 of the Exchange Act.

Key Details

• Date of 8-K and press release: May 7, 2026.
• Reporting period: quarter ended March 31, 2026.
• Press release furnished as Exhibit 99.1 (the Form 8-K does not itself include the financial figures).
• Exhibit contains forward‑looking statements and the filing clarifies those statements are subject to the cautionary language in the release.

Why It Matters

• This filing signals Syra has publicly released its Q1 2026 earnings/quarterly results; investors should review the press release for revenue, earnings, cash flow, or guidance details.
• Because the 8-K furnishes (but does not “file”) the release and highlights forward‑looking statements, investors should read the exhibit carefully and consult other SEC filings for the formal, filed financial statements and disclosures.